Virologic effect and hepatotoxicity of BCR::ABL1 tyrosine kinase inhibitors in cancer patients with chronic hepatitis C virus infection: A prospective study
Article in Leukemia Research (October 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Safety and Efficacy of Imatinib, Nilotinib, and Artesunate in COVID-19 Patients: A Systematic Review of Current Evidence
Article in Anti-Infective Agents (January 2024)
Genetic and pharmacological perturbation of hepatitis-C virus entry
Article in Current Opinion in Virology (September 2023)